In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Dr. Florence Mowlem, VP of Science at ObvioHealth, to discuss maximizing patient accessibility in trial design. This includes implementing accommodations for patients with physical and cognitive limitations, and ensuring thoughtful applications of electronic modalities.
In this episode of TransPerfect LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Dr Michelle Longmire, CEO of...
Artificial intelligence is redefining what’s possible across the clinical development lifecycle, but with rapid innovation comes the need for thoughtful oversight. In this episode...
In our first episode of LifeSci Talks, Global Practice Leader & COA SME of TransPerfect Life Sciences sits down with Dr. Elin Haf Davies,...
